Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

NCT06249048

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • NextGen Oncology Beverly Hills, California, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

The Cancer of the Pancreas Screening-5 CAPS5)Study

NCT02000089

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +47 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dana Farber Cancer Center, Harvard University Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT04370587

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions